Cervomed Inc (CRVO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 10,009 | 6,369 | 7,793 | 10,425 | 15,000 |
| Marketable Securities | 35,083 | N/A | N/A | N/A | N/A |
| Receivables | N/A | N/A | 915 | N/A | N/A |
| Other current assets | 0 | 248 | 0 | 0 | 0 |
| TOTAL | $47,328 | $7,966 | $9,965 | $11,843 | $15,695 |
| Non-Current Assets | |||||
| Investments And Advances | 5,806 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 56 | 32 | 8 | 194 | 0 |
| TOTAL | $5,863 | $32 | $8 | $194 | $N/A |
| Total Assets | $53,191 | $7,997 | $9,973 | $12,038 | $15,695 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 726 | 680 | 663 | 534 | 932 |
| TOTAL | $3,214 | $2,661 | $2,596 | $2,464 | $1,465 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 1,402 | 573 | N/A | 547 | N/A |
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $3,214 | $2,661 | $2,596 | $2,464 | $1,465 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 8,254 | 8,254 | 6,170 | 5,675 | 1,360 |
| Common Shares | 8 | 6 | 6 | 6 | 2 |
| Retained earnings | -59,272 | -56,955 | -54,441 | -52,078 | -151,802 |
| Other shareholders' equity | -20 | 0 | 0 | 0 | 0 |
| TOTAL | $49,977 | $5,336 | $7,377 | $9,574 | $14,230 |
| Total Liabilities And Equity | $53,191 | $7,998 | $9,973 | $12,038 | $15,695 |